Argenica Therapeutics Ltd
AGN•Health Care•Biotechnology•Last updated: Dec 25
About
Argenica Therapeutics Ltd is a biotechnology company focused on developing novel therapeutics to reduce brain tissue death after stroke. The company is engaged in the research and development of neuroprotective therapeutics aimed at improving patient outcomes following brain injuries. Its lead product candidate, ARG-007, is designed to protect brain cells and reduce damage during acute ischemic stroke.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- AGN
Related Shares
Investor Resources
Should you buy Argenica Therapeutics Ltd right now?
While AGN looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now